|
TMEM170B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.44249065417534E-15 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.88737914186277E-15 |
| Normal-vs-Stage2 |
1.0096001812343E-10 |
| Normal-vs-Stage3 |
1.62525548574877E-12 |
| Normal-vs-Stage4 |
1.62447832963153E-12 |
| Stage1-vs-Stage2 |
1.234470E-02 |
| Stage1-vs-Stage3 |
5.906200E-01 |
| Stage1-vs-Stage4 |
8.375600E-02 |
| Stage2-vs-Stage3 |
1.432100E-02 |
| Stage2-vs-Stage4 |
1.562720E-03 |
| Stage3-vs-Stage4 |
2.991800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62525548574877E-12 |
| Normal-vs-AfricanAmerican |
6.48450000362288E-08 |
| Normal-vs-Asian |
1.11022302462516E-16 |
| Caucasian-vs-AfricanAmerican |
4.910400E-01 |
| Caucasian-vs-Asian |
2.885800E-01 |
| AfricanAmerican-vs-Asian |
2.795200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.10782519111308E-15 |
| Normal-vs-Female |
2.1094237467878E-15 |
| Male-vs-Female |
7.798600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.33066907387547E-16 |
| Normal-vs-Age(41-60Yrs) |
1.62725388719309E-12 |
| Normal-vs-Age(61-80Yrs) |
5.7065463465733E-14 |
| Normal-vs-Age(81-100Yrs) |
2.979300E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.766800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.146200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.688160E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.538000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.394590E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.564800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.89659999999936E-05 |
| Classical-VS-Follicular |
1.875080E-03 |
| Classical-VS-Other |
5.051200E-01 |
| Classical-VS-Normal |
1.63247193540883E-12 |
| Tall-VS-Follicular |
2.26580000317611E-08 |
| Tall-VS-Other |
3.264600E-01 |
| Tall-VS-Normal |
1.62436730732907E-12 |
| Follicular-VS-Other |
1.118180E-01 |
| Follicular-VS-Normal |
2.06039629802035E-11 |
| Other-VS-Normal |
6.06610000000174E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.18713935851156E-14 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
1.88810999999234E-05 |
|
|
